Loading insider details...
Latest Form 4 (Aug 18, 2026): Purchase of 10,600 EYPT shares, $52.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | EyePoint, Inc. (EYPT) | Purchase | 10,600 | $52.3K |
| Jan 6, 2026 | EyePoint, Inc. (EYPT) | Grant/Award | 40,000 | n/a |
| Jul 11, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Exercise/Conversion | 2,000 | n/a |
| May 19, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Purchase | 5,000 | $29.0K |
| May 15, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Purchase | 5,000 | $27.1K |
| Jan 7, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/Award | 40,000 | n/a |
| Aug 21, 2024 | EyePoint Pharmaceuticals, Inc. (EYPT) | Purchase | 12,500 | $99.8K |
| Jul 12, 2024 | EyePoint Pharmaceuticals, Inc. (EYPT) | Exercise/Conversion | 2,000 | n/a |
| Mar 25, 2024 | Axogen, Inc. (AXGN) | Exercise/Conversion | 84,847 | n/a |
| Jan 10, 2024 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/Award | 25,014 | n/a |